Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2007

Content (14 Articles)

Review Paper

Paget’s disease of the breast: accuracy of preoperative assessment

Shaheen Zakaria, Gouri Pantvaidya, Karthik Ghosh, Amy C. Degnim

Preclinical Study

Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases

Lurdes Torres, Franclim R. Ribeiro, Nikos Pandis, Johan A. Andersen, Sverre Heim, Manuel R. Teixeira

Preclinical Study

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-κB pathway activation as a potential mechanism of resistance

Héctor Hernández-Vargas, Socorro María Rodríguez-Pinilla, Mercedes Julián-Tendero, Pedro Sánchez-Rovira, Cristóbal Cuevas, Antonio Antón, Maria Jesus Ríos, José Palacios, Gema Moreno-Bueno

Preclinical study

Bad expression predicts outcome in patients treated with tamoxifen

Elizabeth Cannings, Tove Kirkegaard, Sian M. Tovey, Barbara Dunne, T. G. Cooke, John M. S. Bartlett

Clinical Trial

Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors

Jane A. Cauley, Jingli Song, Sherie A. Dowsett, John L. Mershon, Steven R. Cummings

Epidemiology

BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors

Khalid Dafaallah Awadelkarim, Gitana Aceto, Serena Veschi, Ahmed Elhaj, Annalisa Morgano, Ahmed Abdalla Mohamedani, Elgaylani Abdalla Eltayeb, Dafaallah Abuidris, Mario Di Gioacchino, Pasquale Battista, Fabio Verginelli, Alessandro Cama, Nasr Eldin Elwali, Renato Mariani-Costantini

Epidemiology

Impact of newly diagnosed breast cancer on quality of life among Chinese women

Wei Lu, Yong Cui, Ying Zheng, Kai Gu, Hui Cai, Qiong Li, Wei Zheng, Xiao Ou Shu

Epidemiology

Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands

J. H. Groenewoud, J. D. M. Otten, J. Fracheboud, G. Draisma, B. M. van Ineveld, R. Holland, A. L. M. Verbeek, H. J. de Koning

Epidemiology

Improvement of best practice in early breast cancer: actionable surgeon and hospital factors

Marjan Gort, Manda Broekhuis, Renée Otter, Niek S. Klazinga

Original Paper

A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches

Janet E. Olson, James N. Ingle, Cynthia X. Ma, Linda L. Pelleymounter, Daniel J. Schaid, V. Shane Pankratz, Robert A. Vierkant, Zachary S. Fredericksen, Yanhong Wu, Fergus J. Couch, Celine M. Vachon, Thomas A. Sellers, Richard M. Weinshilboum

Erratum

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women

Virendra Singh, Neeraj Rastogi, Ashima Sinha, Abhai Kumar, Neeraj Mathur, Mahendra Pratap Singh

Erratum

Breast cancer and long-term hormonal treatment of male hypogonadism

Marek Medras, Alicja Filus, Paweł Jozkow, Jacek Winowski, Teresa Sicinska-Werner

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine